<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02310217</url>
  </required_header>
  <id_info>
    <org_study_id>LMB03</org_study_id>
    <nct_id>NCT02310217</nct_id>
  </id_info>
  <brief_title>Validation of New Tools for the Assessment of Cognitive Functions and Connectivity Network in Hypertensive Patients</brief_title>
  <official_title>Validation of New Tools for the Assessment of Cognitive Functions and Connectivity Network in Hypertensive Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Neuromed IRCCS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Neuromed IRCCS</source>
  <brief_summary>
    <textblock>
      The relationship among hypertension, aging and cognitive decline is complex and not
      completely understood. Purpose of this project will be evaluating early markers of cognitive
      deterioration in patients with arterial hypertension. In particular, this cross-sectional
      observational study will be articulated in three phases:

        1. Neuropsychological evaluation of general cognitive abilities

        2. Identification and measurement of specific biomarker levels

        3. Correlation among hypertension, cognitive abilities and biomarkers.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cognitive abilities measured by validated neuropsychological test battery (Montreal Cognitive Assessment test, Verbal Fluency test,learning of couple words, Stroop test)</measure>
    <time_frame>18 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Hypertension</condition>
  <condition>Cognitive Impairment</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Hypertensive</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Normotensive</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be selected from the Department of Angiocardioneurology and Translational
        Medicine of the IRCCS Neuromed, according to specific inclusion criteria. Approximatey 80
        subjects per group, aged between 40 and 65 years, will be included in the study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males or females diagnosed with arterial hypertension between 40 and 65 years of age;

          -  Written informed consent prior to enrollment in the study.

        Exclusion Criteria:

          -  Precedent acute myocardial infarction (AMI);

          -  Previous stroke and/or transient ischemic attack (TIA);

          -  Previous or concomitant neurologic or psychiatric pathologies;

          -  Neurologic or psychiatric pharmacological therapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Giuseppe Lembo, MD, PhD</last_name>
    <phone>+39 0865.915225</phone>
    <email>lembo@neuromed.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>IRCCS Neuromed</name>
      <address>
        <city>Pozzilli</city>
        <state>(is)</state>
        <zip>86077</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Giuseppe Lembo, prof., MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Giulio Selvetella, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniela Carnevale, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 28, 2014</study_first_submitted>
  <study_first_submitted_qc>December 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2014</study_first_posted>
  <last_update_submitted>December 14, 2017</last_update_submitted>
  <last_update_submitted_qc>December 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Neuromed IRCCS</investigator_affiliation>
    <investigator_full_name>Giuseppe Lembo</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Hypertension</keyword>
  <keyword>Cognitive impairment</keyword>
  <keyword>Biomarkers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

